Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is an 83.3% decrease from the number of companies cited in the previous year.
The citations in the county include:
- You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.
- You did not confirm the identity of components.
- You did not establish and follow written procedures for quality control operations.
The company cited was involved in the Food and Cosmetics sector.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Liquid Assets, Inc. | Food and Cosmetics | 04/27/2023 | Specifications - identity, purity, strength, composition |
Liquid Assets, Inc. | Food and Cosmetics | 04/27/2023 | Component - confirm identity; specifications met |
Liquid Assets, Inc. | Food and Cosmetics | 04/27/2023 | Written procedures - quality control operations |
Liquid Assets, Inc. | Food and Cosmetics | 04/27/2023 | Written procedures - labeling operations |
Liquid Assets, Inc. | Food and Cosmetics | 04/27/2023 | Written procedures - holding |
Liquid Assets, Inc. | Food and Cosmetics | 04/27/2023 | Written procedures - returned dietary supplement |
Liquid Assets, Inc. | Food and Cosmetics | 04/27/2023 | Written procedures - product complaint |